Characterization of regulatory T cells in patients with dermatomyositis.
about
The injury-induced myokine insulin-like 6 is protective in experimental autoimmune myositisAberrant muscle antigen exposure in mice is sufficient to cause myositis in a Treg cell-deficient milieuIdiopathic inflammatory myopathies.Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligoGenomic signatures characterize leukocyte infiltration in myositis muscles.Pathogenesis of dermatomyositis: role of cytokines and interferon.Th1 response and systemic treg deficiency in inclusion body myositis.The tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy.Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.T cells in myositis.Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.Regulatory T cells and skeletal muscle regeneration.The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis.Zinc enhances the number of regulatory T cells in allergen-stimulated cells from atopic subjects.Role of regulatory T cells in patients with acute herpes zoster and relationship to postherpetic neuralgia.T regulatory cells and related immunoregulatory factors in polymorphic light eruption following ultraviolet A1 challenge.Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro-apoptotic subsets.T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients.T regulatory cells and other lymphocyte subsets in patients with bullous pemphigoid.Current Insights in Microbiome Shifts in Sjogren's Syndrome and Possible Therapeutic Interventions.
P2860
Q30586295-D5EF7ECE-88E6-475A-A783-5B5DA3655A44Q33661671-C8707FA3-1E4B-4E3A-9F83-210335F6955FQ33924451-1EE684D3-0C24-4DCB-B8CF-CE98F75C8138Q34287499-E552FC9B-D023-470E-870A-9D5057C96989Q34484782-E3898F2F-95EC-42B0-BB05-F344F3477751Q34626955-D121CF87-7355-4D47-ADC5-C9B9A8B574A5Q35110718-1A40701D-D660-4663-BC92-A0068CAF9BA2Q35450066-2A2B30C5-A2B1-406F-9524-06C70D6D32B1Q37938701-0E3C9708-BE98-48B8-8B37-2DF4E69385A2Q38070033-6E2C2A78-4D9F-414C-9189-F18CF62829DEQ38244567-1CDC4A74-A7FC-487C-9CE6-97A35C1E65F0Q38915073-1CA22E33-4967-44DE-80E3-92D3A61A8AE0Q39510961-4D699485-21AF-4ECA-A00B-E243D58E1A58Q40295262-260ABDC0-86C5-49C0-8943-7272381B7C69Q43526924-7AF63A1E-B626-446E-81D5-9BE17EB46D8AQ45941162-2FC0D453-BF67-4B84-BB92-CF2C452E28D2Q46730821-1480D287-5CF8-451E-B910-7F050417119DQ47367610-ABFC93A5-08D7-494E-8B65-9BBC6680F9DFQ53669315-B148222F-4F43-4F58-9BA6-79FF60ACF573Q54058367-CAA767C8-EA89-42DC-B480-F74FD8E18E3EQ55294689-1840F5FE-7533-4979-8A14-1CB2F0920793
P2860
Characterization of regulatory T cells in patients with dermatomyositis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Characterization of regulatory T cells in patients with dermatomyositis.
@en
Characterization of regulatory T cells in patients with dermatomyositis.
@nl
type
label
Characterization of regulatory T cells in patients with dermatomyositis.
@en
Characterization of regulatory T cells in patients with dermatomyositis.
@nl
prefLabel
Characterization of regulatory T cells in patients with dermatomyositis.
@en
Characterization of regulatory T cells in patients with dermatomyositis.
@nl
P2093
P1476
Characterization of regulatory T cells in patients with dermatomyositis.
@en
P2093
E Del Bianco
M Hartmann
P304
P356
10.1016/J.JAUT.2010.07.006
P577
2010-09-16T00:00:00Z